Rie Horii

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Epidermal Growth Factor Receptor

Positive Breast Cancer

Endoplasmic Reticulum

Top Venues

Breast cancer (Tokyo, Japan)

Cancer medicine

Virchows Archiv : an international journal of pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Natsuki Teruya, Hiroaki Inoue, Rie Horii, Futoshi Akiyama, Takayuki Ueno, Shinji Ohno, Shunji Takahashi
Intratumoral heterogeneity, treatment response, and survival outcome of ER-positive HER2-positive breast cancer. Cancer medicine (2023)
Rie Horii, Hiroaki Nitta, Masanori Nojima, Reo Maruyama, Takayuki Ueno, Yoshinori Ito, Shinji Ohno, Peter Banks, Hiroaki Kanda, Futoshi Akiyama
Predictive significance of HER2 intratumoral heterogeneity, determined by simultaneous gene and protein analysis, for resistance to trastuzumab-based treatments for HER2-positive breast cancer. Virchows Archiv : an international journal of pathology 479 (1) (2021)
Rie Horii, Hitoshi Tsuda, Shinobu Masuda, Hironobu Sugita, Kenichi Togashi, Shinji Ohno, Futoshi Akiyama
Performance analysis of the anti-Ki67 antibody clone 30-9 for immunohistochemical staining of breast cancer. Breast cancer (Tokyo, Japan) 27 (6) (2020)
Hiroaki Inoue, Rie Horii, Yoshinori Ito, Takuji Iwase, Shinji Ohno, Futoshi Akiyama
Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer. Breast cancer (Tokyo, Japan) 25 (3) (2017)